RMD 13F position history: Francois Rochon - Giverny Capital
ResMed Inc, as reported in Francois Rochon - Giverny Capital’s quarterly 13F filings. See all fund managers holding RMD.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | Added | 387,665 | $75,548,155 | 2.54% | $194.88 | Filing |
| Q1 2026 | Trimmed | 230,005 | $51,631,522 | 1.89% | $224.48 | Filing |
| Q4 2025 | Trimmed | 235,388 | $56,697,908 | 1.89% | $240.87 | Filing |
| Q3 2025 | New | 235,418 | $64,440,969 | 2.18% | $273.73 | Filing |
| Q1 2023 | Sold out | — | — | 0.00% | — | Filing |
| Q4 2022 | No change | 437 | $90,953 | 0.01% | $208.13 | Filing |
| Q3 2022 | No change | 437 | $95,000 | 0.01% | $217.39 | Filing |
| Q2 2022 | No change | 437 | $92,000 | 0.01% | $210.53 | Filing |
| Q1 2022 | No change | 437 | $106,000 | 0.01% | $242.56 | Filing |
| Q4 2021 | No change | 437 | $114,000 | 0.01% | $260.87 | Filing |
| Q3 2021 | No change | 437 | $115,000 | 0.01% | $263.16 | Filing |
| Q2 2021 | No change | 437 | $108,000 | 0.01% | $247.14 | Filing |
| Q1 2021 | No change | 437 | $85,000 | 0.01% | $194.51 | Filing |
| Q4 2020 | No change | 437 | $93,000 | 0.01% | $212.81 | Filing |
| Q3 2020 | New | 437 | $75,000 | 0.01% | $171.62 | Filing |